nach oben

Current Reviews in Musculoskeletal Medicine

Erschienen in:

01.12.2012 | Health Policy (AD Sharan, Section Editor)

Assessing the value of a total joint replacement

verfasst von: David B. Bumpass, Ryan M. Nunley

Erschienen in: Current Reviews in Musculoskeletal Medicine | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Total joint arthroplasty (TJA) continues to be one of the most successful surgical interventions in medicine. Demand is growing rapidly, placing an increasingly heavy cost burden on national health systems. Despite the popularity of these surgeries, high-quality cost-effectiveness studies evaluating TJA are few in number. This article summarizes the current literature on value in arthroplasty, identifying the various factors affecting costs and outcomes, and suggesting how policy makers can influence utilization of TJA to further improve value to society.

Learmonth ID, Young C, Rorabeck C. The operation of the century: total hip replacement. Lancet. 2007;370:1508–19.PubMedCrossRef

Wilson NA, Schneller ES, Montgomery K, Bozic KJ. Hip and knee implants: current trends and policy considerations. Health Aff (Millwood). 2008;27:1587–98.CrossRef

Kurtz S, Mowat F, Ong K, Chan N, Lau E, Halpern M. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am. 2005;87:1487–97.PubMedCrossRef

Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780–5.PubMedCrossRef

Bourne RB. Measuring tools for functional outcomes in total knee arthroplasty. Clin Orthop Relat Res. 2008;466:2634–8.PubMedCrossRef

Ethgen O, Bruyere O, Richy F, Dardennes C, Reginster JY. Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am. 2004;86-A:963–74.PubMed

Feeny D, Blanchard CM, Mahon JL, et al. The stability of utility scores: test-retest reliability and the interpretation of utility scores in elective total hip arthroplasty. Qual Life Res. 2004;13:15–22.PubMedCrossRef

Ostendorf M, van Stel HF, Buskens E, et al. Patient-reported outcome in total hip replacement. A comparison of 5 instruments of health status. J Bone Joint Surg Br. 2004;86:801–8.PubMedCrossRef

Bozic KJ, Saleh KJ, Rosenberg AG, Rubash HE. Economic evaluation in total hip arthroplasty: analysis and review of the literature. J Arthroplasty. 2004;19:180–9.PubMedCrossRef

10.

Liang MH, Cullen KE, Larson MG, et al. Cost-effectiveness of total joint arthroplasty in osteoarthritis. Arthritis Rheum. 1986;29:937–43.PubMedCrossRef

11.

Rorabeck CH, Bourne RB, Laupacis A, et al. A double-blind study of 250 cases comparing cemented with cementless total hip arthroplasty. Cost-effectiveness and its impact on health-related quality of life. Clin Orthop Relat Res. 1994;298:156–64.

12.

Laupacis A, Bourne R, Rorabeck C, et al. The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am. 1993;75:1619–26.PubMed

13.

Laupacis A, Bourne R, Rorabeck C, et al. Costs of elective total hip arthroplasty during the first year. Cemented vs noncemented. J Arthroplasty. 1994;9:481–7.PubMedCrossRef

14.

Chang RW, Pellisier JM, Hazen GB. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA. 1996;275:858–65.PubMedCrossRef

15.

James M, St Leger S, Rowsell KV. Prioritising elective care: a cost utility analysis of orthopaedics in the north west of England. J Epidemiol Community Health. 1996;50:182–9.PubMedCrossRef

16.

Rissanen P, Aro S, Sintonen H, Asikainen K, Slatis P, Paavolainen P. Costs and cost-effectiveness in hip and knee replacements. A prospective study. Int J Technol Assess Health Care. 1997;13:575–88.PubMedCrossRef

17.

Rasanen P, Paavolainen P, Sintonen H, et al. Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs. Acta Orthop. 2007;78:108–15.PubMedCrossRef

18.

Lawless BM, Greene M, Slover J, Kwon YM, Malchau H. Does age or bilateral disease influence the value of hip arthroplasty? Clin Orthop Relat Res. 2012;470:1073–8.PubMedCrossRef

19.

• Tso P, Walker K, Mahomed N, Coyte PC, Rampersaud YR. Comparison of lifetime incremental cost:utility ratios of surgery relative to failed medical management for the treatment of hip, knee, and spine osteoarthritis modelled using 2-year postsurgical values. Can J Surg. 2012;55:181–90. This study presents prospective data comparing the cost utility of medical vs surgical management of hip, knee, and spine arthritis.PubMedCrossRef

20.

Fordham R, Skinner J, Wang X, Nolan J. The economic benefit of hip replacement: a 5-year follow-up of costs and outcomes in the exeter primary outcomes study. BMJ 2012;2:e000752.

21.

Lavernia CJ, Guzman JF, Gachupin-Garcia A. Cost effectiveness and quality of life in knee arthroplasty. Clin Orthop Relat Res. 1997;345:134–9.

22.

Krummenauer F, Wolf C, Gunther KP, Kirschner S. Clinical benefit and cost effectiveness of total knee arthroplasty in the older patient. Eur J Med Res. 2009;14:76–84.PubMedCrossRef

23.

• Dakin H, Gray A, Fitzpatrick R, Maclennan G, Murray D. Rationing of total knee replacement: a cost-effectiveness analysis on a large trial data set. BMJ. 2012;2:e000332. This study models the economic implications of TKA rationing in the British health system; the study had a large number of patients, 5-year follow-up, and a sensitivity analysis.

24.

Koskinen E, Eskelinen A, Paavolainen P, Pulkkinen P, Remes V. Comparison of survival and cost-effectiveness between unicondylar arthroplasty and total knee arthroplasty in patients with primary osteoarthritis: a follow-up study of 50,493 knee replacements from the finnish arthroplasty register. Acta Orthop. 2008;79:499–507.PubMedCrossRef

25.

Ong KL, Mowat FS, Chan N, Lau E, Halpern MT, Kurtz SM. Economic burden of revision hip and knee arthroplasty in medicare enrollees. Clin Orthop Relat Res. 2006;446:22–8.PubMedCrossRef

26.

Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am. 2009;91:128–33.PubMedCrossRef

27.

Bozic KJ, Kurtz SM, Lau E, et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res. 2010;468:45–51.PubMedCrossRef

28.

Bozic KJ, Katz P, Cisternas M, Ono L, Ries MD, Showstack J. Hospital resource utilization for primary and revision total hip arthroplasty. J Bone Joint Surg Am. 2005;87:570–6.PubMedCrossRef

29.

Bozic KJ, Durbhakula S, Berry DJ, et al. Differences in patient and procedure characteristics and hospital resource use in primary and revision total joint arthroplasty: a multicenter study. J Arthroplasty. 2005;20:17–25.PubMedCrossRef

30.

Burns AW, Bourne RB, Chesworth BM, MacDonald SJ, Rorabeck CH. Cost effectiveness of revision total knee arthroplasty. Clin Orthop Relat Res. 2006;446:29–33.PubMedCrossRef

31.

Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008;23:984–91.PubMedCrossRef

32.

• Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty. 2012;27(8 suppl):61–65. This study presents data on the increasing burden of TJA infection to the health system, and projects trends for future increases.

33.

Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. 2005;87:1746–51.PubMedCrossRef

34.

Vanhegan IS, Malik AK, Jayakumar P, Ul Islam S, Haddad FS. A financial analysis of revision hip arthroplasty: the economic burden in relation to the national tariff. J Bone Joint Surg Br. 2012;94:619–23.PubMedCrossRef

35.

Bozic KJ, Chiu VW, Slover JD, Immerman I, Kahn JG. Health state utility in patients with osteoarthritis of the hip and total hip arthroplasty. J Arthroplasty. 2011;26:129–32. e1–2.PubMedCrossRef

36.

Fisman DN, Reilly DT, Karchmer AW, Goldie SJ. Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis. 2001;32:419–30.PubMedCrossRef

37.

Faulkner A, Kennedy LG, Baxter K, Donovan J, Wilkinson M, Bevan G. Effectiveness of hip prostheses in primary total hip replacement: a critical review of evidence and an economic model. Health Technol Assess. 1998;2:1–133.PubMed

38.

Fitzpatrick R, Shortall E, Sculpher M, et al. Primary total hip replacement surgery: a systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses. Health Technol Assess. 1998;2:1–64.PubMed

39.

Gillespie WJ, Pekarsky B, O'Connell DL. Evaluation of new technologies for total hip replacement. Economic modelling and clinical trials. J Bone Joint Surg Br. 1995;77:528–33.PubMed

40.

Bozic KJ, Morshed S, Silverstein MD, Rubash HE, Kahn JG. Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics. The case of alternative bearing surfaces in total hip arthroplasty. J Bone Joint Surg Am. 2006;88:706–14.PubMedCrossRef

41.

Anderson KC, Buehler KC, Markel DC. Computer assisted navigation in total knee arthroplasty: comparison with conventional methods. J Arthroplasty. 2005;20:132–8.PubMedCrossRef

42.

Chin PL, Yang KY, Yeo SJ, Lo NN. Randomized control trial comparing radiographic total knee arthroplasty implant placement using computer navigation vs conventional technique. J Arthroplasty. 2005;20:618–26.PubMedCrossRef

43.

Mason JB, Fehring TK, Estok R, Banel D, Fahrbach K. Meta-analysis of alignment outcomes in computer-assisted total knee arthroplasty surgery. J Arthroplasty. 2007;22:1097–106.PubMedCrossRef

44.

Molli RG, Anderson KC, Buehler KC, Markel DC. Computer-assisted navigation software advancements improve the accuracy of total knee arthroplasty. J Arthroplasty. 2011;26:432–8.PubMedCrossRef

45.

Blakeney WG, Khan RJ, Wall SJ. Computer-assisted techniques vs conventional guides for component alignment in total knee arthroplasty: a randomized controlled trial. J Bone Joint Surg Am. 2011;93:1377–84.PubMedCrossRef

46.

Beringer DC, Patel JJ, Bozic KJ. An overview of economic issues in computer-assisted total joint arthroplasty. Clin Orthop Relat Res. 2007;463:26–30.PubMed

47.

Novak EJ, Silverstein MD, Bozic KJ. The cost-effectiveness of computer-assisted navigation in total knee arthroplasty. J Bone Joint Surg Am. 2007;89:2389–97.PubMedCrossRef

48.

Slover JD, Tosteson AN, Bozic KJ, Rubash HE, Malchau H. Impact of hospital volume on the economic value of computer navigation for total knee replacement. J Bone Joint Surg Am. 2008;90:1492–500.PubMedCrossRef

49.

Martineau P, Filion KB, Huk OL, Zukor DJ, Eisenberg MJ, Antoniou J. Primary hip arthroplasty costs are greater in low-volume than in high-volume Canadian hospitals. Clin Orthop Relat Res. 2005;152–6.

50.

Zuckerman JD, Kummer FJ, Frankel VH. The effectiveness of a hospital-based strategy to reduce the cost of total joint implants. J Bone Joint Surg Am. 1994;76:807–11.PubMed

51.

Scranton Jr PE. The cost effectiveness of streamlined care pathways and product standardization in total knee arthroplasty. J Arthroplasty. 1999;14:182–6.PubMedCrossRef

52.

Healy WL, Iorio R, Ko J, Appleby D, Lemos DW. Impact of cost reduction programs on short-term patient outcome and hospital cost of total knee arthroplasty. J Bone Joint Surg Am. 2002;84-A:348–53.PubMed

53.

Barbieri A, Vanhaecht K, Van Herck P, et al. Effects of clinical pathways in the joint replacement: a meta-analysis. BMC Med. 2009;7:32.PubMedCrossRef

54.

Krummenauer F, Guenther KP, Kirschner S. Cost effectiveness of total knee arthroplasty from a health care providers' perspective before and after introduction of an interdisciplinary clinical pathway–is investment always improvement? BMC Health Serv Res. 2011;11:338.PubMedCrossRef

55.

Larsen K, Hansen TB, Thomsen PB, Christiansen T, Soballe K. Cost-effectiveness of accelerated perioperative care and rehabilitation after total hip and knee arthroplasty. J Bone Joint Surg Am. 2009;91:761–72.PubMedCrossRef

56.

Larsen K, Hvass KE, Hansen TB, Thomsen PB, Soballe K. Effectiveness of accelerated perioperative care and rehabilitation intervention compared with current intervention after hip and knee arthroplasty. A before-after trial of 247 patients with a 3-month follow-up. BMC Musculoskelet Disord. 2008;9:59.PubMedCrossRef

57.

Mahomed NN, Davis AM, Hawker G, et al. Inpatient compared with home-based rehabilitation following primary unilateral total hip or knee replacement: a randomized controlled trial. J Bone Joint Surg Am. 2008;90:1673–80.PubMedCrossRef

58.

Khan F, Ng L, Gonzalez S, Hale T, Turner-Stokes L. Multidisciplinary rehabilitation programmes following joint replacement at the hip and knee in chronic arthropathy. Cochrane Database Syst Rev. 2008;16:CD004957.

59.

Saleh KJ, Wood KC, Gafni A, Gross AE. Immediate surgery vs waiting list policy in revision total hip arthroplasty. An economic evaluation. J Arthroplasty. 1997;12:1–10.PubMedCrossRef

60.

Mahon JL, Bourne RB, Rorabeck CH, Feeny DH, Stitt L, Webster-Bogaert S. Health-related quality of life and mobility of patients awaiting elective total hip arthroplasty: a prospective study. CMAJ. 2002;167:1115–21.PubMed

61.

Kili S, Wright I, Jones RS. Change in harris hip score in patients on the waiting list for total hip replacement. Ann R Coll Surg Engl. 2003;85:269–71.PubMedCrossRef

62.

McKee J. AJRR continues to expand. AAOS Now. 2012;3. http://www.aaos.org/news/aaosnow/mar12/research1.asp

63.

Metz CM, Freiberg AA. An international comparative study of total hip arthroplasty cost and practice patterns. J Arthroplasty. 1998;13:296–8.PubMedCrossRef

64.

Newman J, Grobman WA, Greenland P. Combination polypharmacy for cardiovascular disease prevention in men: a decision analysis and cost-effectiveness model. Prev Cardiol. 2008;11:36–41.PubMedCrossRef

65.

Al-Ruzzeh S, Epstein D, George S, et al. Economic evaluation of coronary artery bypass grafting surgery with and without cardiopulmonary bypass: cost-effectiveness and quality-adjusted life years in a randomized controlled trial. Artif Organs. 2008;32:891–7.PubMedCrossRef

66.

Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med. 2011;155:10–20.PubMed

67.

Kontodimopoulos N, Niakas D. An estimate of lifelong costs and QALYs in renal replacement therapy based on patients' life expectancy. Health Policy. 2008;86:85–96.PubMedCrossRef

68.

Moreno SG, Novielli N, Cooper NJ. Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation. J Heart Lung Transplant. 2012;31:450–8.PubMedCrossRef

69.

Ho KM, Honeybul S, Lind CRP, Gillett GR, Litton E. Cost-effectiveness of decompressive craniectomy as a lifesaving rescue procedure for patients with severe traumatic brain injury. J Trauma. 2011;71:1637–44.PubMedCrossRef

70.

Garellick G, Malchau H, Herberts P, et al. Life expectancy and cost utility after total hip replacement. Clin Orthop Relat Res. 1998;346:141–51.PubMedCrossRef

Titel: Assessing the value of a total joint replacement
verfasst von: David B. Bumpass
Ryan M. Nunley
Publikationsdatum: 01.12.2012
Verlag: Current Science Inc.
Erschienen in: Current Reviews in Musculoskeletal Medicine / Ausgabe 4/2012
Elektronische ISSN: 1935-9748
DOI: https://doi.org/10.1007/s12178-012-9139-6

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

25.04.2024 | Hypertonie | Nachrichten

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Assessing the value of a total joint replacement

Abstract

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Update Orthopädie und Unfallchirurgie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2012

The role of accountable care organizations in delivering value

Evolution of customization design for total knee arthroplasty

Design rationale for customized TKA: a new idea or revisiting the past?

The use of customized TKA implants for increased efficiency in the OR

Erratum to: Femoroacetabular impingement: a review of diagnosis and management

Brief history of quality movement in US healthcare

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Update Orthopädie und Unfallchirurgie